Matthew Wilson Archives
American Society for Clinical Investigation honors 10 Vanderbilt physicians
Feb. 9, 2023—by Bill Snyder Four Vanderbilt University Medical Center faculty members have been elected this year to membership in the American Society for Clinical Investigation (ASCI), the organization has announced. Four others from VUMC have received ASCI Council Young Physician Scientist Awards this year, and two have received ASCI Emerging Generation Awards. Founded in 1908, the...
Wilson appointed to ASGCT board of directors
May. 2, 2019—The American Society of Gene and Cell Therapy (ASGCT) has appointed Matthew Wilson, MD, PhD, associate professor of Medicine in Vanderbilt’s Division of Nephrology and Hypertension, to its board of directors. Beginning in May 2019, Wilson will serve a three-year term as an at-large director.
Reprogramming cells for kidney repair
Mar. 14, 2019—Using gene transfer technologies to reprogram adult human kidney cells could lead to novel therapies for chronic kidney disease.
Vanderbilt scientists test potential new way to treat anemia
Apr. 10, 2018—Treatment of anemia caused by chronic kidney disease or other diseases often requires repeated — and costly — injections or infusions of an artificial form of the hormone erythropoietin (EPO), which stimulates production of red blood cells.